Gefan 45 mg tablet
Generic: Gefapixant Citrate
Company: Everest Pharmaceuticals Ltd.. Prices are as listed on BestinMeds; your pharmacy price may differ.
Reviewed by: not listed yet. Source: not listed yet.
Last updated December 1, 2025.
Generic: Gefapixant Citrate
Company: Everest Pharmaceuticals Ltd.. Prices are as listed on BestinMeds; your pharmacy price may differ.
Reviewed by: not listed yet. Source: not listed yet.
Last updated December 1, 2025.
Sorted by price per tablet. Ask your pharmacist before you switch brands.
Prices as listed on BestinMeds.
Advertisement
What this medicine is for, how to take it, and what to watch for.
Read the full Gefapixant Citrate guide
Gefapixant tablet is indicated in the treatment of- Refractory chronic cough or Unexplained chronic cough in adults.
Treatment with Gefapixant should be initiated and monitored by physicians experienced in managing patients with chronic cough disorders. Adult patients: One 45 mg tablet orally twice daily with or without food. Patients should be advised that if a missed dose is missed, they should skip it and take the next dose at the regular time. Use in elderly patients: No dose adjustment of Gefapixant due to age is required and no age-specific differences in the efficacy or safety of Gefapixant has been established. This medicine is essentially excreted by the kidneys. Since older patients are more likely to have impaired renal function, the risk of adverse effects may be higher in these patients. Caution should be exercised at the initial dosing frequency. Use in the pediatric population: The safety and efficacy of Gefapixant have not been established in patients below 18 years of age. Obstructive sleep apnea: Gefapixant should not be used in patients with refractory chronic cough or unexplained chronic cough and comorbid obstructive sleep apnoea. Patients with liver disease: Gefapixant has not been studied in patients with hepatic impairment. Patients with renal impairment: The recommended dose of Gefapixant in patients with severe impairment (eGFR30 ml/minute/1.73 m2). In patients with severe renal impairment (eGFR
Very Common side effects are dysgeusia, ageusia, hypogeusia. Frequent side effects are upper respiratory tract infections, decreased appetite, taste disturbance, dizziness, nausea, diarrhea, dry mouth, hypersalivation, epigastric pain, dyspepsia, oral hypoesthesia, oral paresthesia etc. Occasionally: Urinary stones, bladder stones, nephrolithiasis are seen
Gefan should be used with caution in patients with known hypersensitivity to sulphonamides.
The use of Gefapixant in women during pregnancy has not been studied. As a precautionary measure, the use of Gefapixant during pregnancy and in women of childbearing potential who do not use contraception is not recommended. It is not known whether gefapixant is present in human breast milk, affects milk formation, or has an effect on breastfed infants. Gefapixant has been detected in milk in animal studies. Fertility: There are no clinical data on the effects of Gefapixant on fertility in humans. Animal studies showed no impairment of fertility.
Gefapixant is a selective antagonist of the P2X3 receptor. P2X3-containing receptors belong to the family of purinergic receptors and are ATP-dependent ion channels, which are also located on sensory C-fibers of the vagus nerve in the airways. C-fibers are activated in response to inflammation or chemical irritants. Under inflammatory conditions, ATP is released by mucosal cells of the respiratory tract. The binding of extracellular ATP to P2X3 receptors is recognized by C-fibers as a damage signal and is perceived as a coughing stimulus, which in turn triggers a cough reflex. Gefapixant blocks ATP-mediated activation of P2X3 receptors, which are thought to be responsible for chronic cough.
Effect of proton pump inhibitor: Concomitant use of the proton pump inhibitor omeprazole had no clinically meaningful effect on the pharmacokinetics of gefapixant. Potential influence of Gefapixant on other medicines: Based on in vitro studies, the potential of Gefapixant for CYP inhibition or induction is low. Effect of Gefapixant on other medicines: No clinically dependent drug interactions have been identified. Effect of other medicines on Gefapixant: No clinically meaningful drug interactions have been identified.
This information is not available. Ask your doctor or pharmacist.
Patient should be observed for adverse reactions and appropriate symptomatic treatment initiated. Gefapixant is partially removed by hemodialysis.
This information is not available. Ask your doctor or pharmacist.
Store below 30°C in a cool and dry place. Keep away from light. Keep out of the reach of children.
BestinMeds shares medicine information to help you compare. It does not replace advice from your doctor or pharmacist.
Advertisement
No other Gefan products are listed yet.
Advertisement